Model-based approach predicts drug levels in leukemia treatment, suggesting improved efficacy and reduced toxicity.
Allopurinol co-treatment reduces toxicity while maintaining therapeutic efficacy at lower 6-MP doses. The proposed model warrants prospective evaluation for clinical relevance confirmation.
No takes yet. Share an insight, caveat, or question.
Ravix et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: